Assyro AI

Orange Book product · Brand (NDA)

STRIVERDI RESPIMAT

OLODATEROL HYDROCHLORIDE

Brand (NDA)NDA 203108RX BOEHRINGER INGELHEIM

At a glance

Jul 31, 2014

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 31, 2014

    12 yr 1 mo ago

  2. Today

  3. Patent 7727984 expires

    Listed drug substance patent expiration.

    Jan 19, 2027

    in 7 mo

Pharmaceutical detail

Active ingredient

OLODATEROL HYDROCHLORIDE

Strength

EQ 0.0025MG BASE/INH

Dosage form

SPRAY, METERED

Route

INHALATION

TE code

Not listed

Application

NDA 203108

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7727984Jan 19, 2027in 7 mo
Substance
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.